Insights into Molecular cancer therapy: NOS-2 suppresses the expression of tumor suppressor p53 homologue TAp63 via up regulation of its target gene, 20/February/2014, 7.43 am

Molecular insights into the regulation of muscle stem cell population :Tumor suppressor p53 promotes progressive muscle wasting via up regulation of its target gene, 20/February/2014, 7.23 am
February 20, 2014
Therapeutic insights into the activation of p53/ARF-dependent tumor suppressor pathway: Genistein suppresses the negative regulator of p53, HDM4 via up regulation of its target gene, 20/February/2014, 7.49 am
February 20, 2014
Show all

Noble Laureate in Medicine (1998) Prof. Dr Ferid M  (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers.  

In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Molecular insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor p53 homologue TAp63  via up regulation of its target gene. This study provides mechanistic insights into how inhibition of NOS-2 may improve caner therapy.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into Molecular cancer therapy: NOS-2 suppresses the expression of tumor suppressor p53 homologue TAp63 via up regulation of its target gene, 20/February/2014, 7.43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

 

Comments are closed.